Morin, A., Soane, C., Pierce, A., Alimova, I., Desmarais, M., Zahedi, S., . . . Levy, J. M. (2018). ATRT-18. VALIDATION OF PROTEASOME INHIBITION AS A THERAPEUTIC TARGET IN ATYPICAL TERATOID/RHABDOID TUMORS. Neuro Oncol.
शिकागो स्टाइल उद्धरणMorin, Andrew, et al. "ATRT-18. VALIDATION OF PROTEASOME INHIBITION AS A THERAPEUTIC TARGET IN ATYPICAL TERATOID/RHABDOID TUMORS." Neuro Oncol 2018.
एमएलए उद्धरणMorin, Andrew, et al. "ATRT-18. VALIDATION OF PROTEASOME INHIBITION AS A THERAPEUTIC TARGET IN ATYPICAL TERATOID/RHABDOID TUMORS." Neuro Oncol 2018.
चेतावनी: ये उद्धरण हमेशा 100% सटीक नहीं हो सकते हैं.